Baskett T F, Parsons M L, Peddle L J
CMAJ. 1986 Jun 1;134(11):1259-61.
A program to reduce the incidence of erythroblastosis fetalis was started in Nova Scotia in 1964. Up to the end of 1984, 120 fetuses received 247 intrauterine transfusions. The survival rate was 45.6% in the first 10 years of the program and 66.7% in the next 11 years. For fetuses at or over 26 weeks' gestation the figures were 51.5% and 73.7% respectively. Postpartum prevention was started in 1968, with administration of Rh immune globulin (RhIG) to Rh-negative unimmunized women within 72 hours after the birth of an Rh-positive infant. Antepartum prevention, started in 1979, consisted of administration of RhIG at 28 weeks' gestation to Rh-negative unimmunized women. The effectiveness of the prevention program was evaluated by enumerating the known cases of Rh(D) alloimmunization in the province from 1982 to 1984: 55 cases were identified, a rate of 1.5 per 1000 births instead of the expected rate of about 10 per 1000.
1964年,新斯科舍省启动了一项降低胎儿成红细胞增多症发病率的计划。截至1984年底,120名胎儿接受了247次宫内输血。该计划实施的前10年存活率为45.6%,后11年为66.7%。对于妊娠26周及以上的胎儿,这两个数字分别为51.5%和73.7%。产后预防于1968年开始,在Rh阳性婴儿出生后72小时内,给Rh阴性未免疫的妇女注射Rh免疫球蛋白(RhIG)。产前预防于1979年开始,在妊娠28周时给Rh阴性未免疫的妇女注射RhIG。通过统计该省1982年至1984年已知的Rh(D)同种免疫病例来评估预防计划的效果:共识别出55例,发病率为每1000例出生中有1.5例,而非预期的每1000例约10例。